Dierks Jeffrey

CHIEF COMMERCIAL OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Jan 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$552K
Net Open-Market Flow
-$552K
Transactions
10
6 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2025Sell(S)2K$38.02$62K0
Jan 24, 2025Sell(S)8K$36.94$296K5K
Jan 24, 2025Option exercise(M)3K$03K
Jan 24, 2025Tax withholding(F)1K$38.01$40K2K
Jan 24, 2025Sell(S)5K$37.87$194K0
Jan 24, 2025Option exercise(M)13K$30.69$403K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 25, 2025Grant(A)13K$013K
Jan 25, 2025Grant(A)47K$047K
Jan 24, 2025Option exercise(M)13K$039K
Jan 24, 2025Option exercise(M)3K$08K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002160) within minutes of acceptance. Every field above traces to the original document. Verify it directly: